What is Pacifica Pharmacy?
Pacifica Pharmacy operates as a specialized compounding pharmacy, distinguishing itself through a focus on bespoke therapeutic solutions. The company provides critical services in pain management, hormone therapy, and specialized pet medication, catering to a demographic that requires highly customized pharmaceutical interventions. By prioritizing concierge-quality care, Pacifica Pharmacy bridges the gap between traditional retail pharmacy services and the growing demand for personalized medicine. Their market position is defined by a commitment to high-quality compounding standards, ensuring that individual patient needs are met with precision and clinical expertise.
How much funding has Pacifica Pharmacy raised?
Pacifica Pharmacy has raised a total of $87K across 1 funding round:
Debt
$87K
Debt (2021): $87K with participation from PPP
Key Investors in Pacifica Pharmacy
PPP
Public-Private Partnership
What's next for Pacifica Pharmacy?
With the recent infusion of capital, Pacifica Pharmacy is expected to accelerate its strategic initiatives, likely focusing on infrastructure expansion and the broadening of its therapeutic service offerings. As the company navigates the Series B/C stage, the focus will shift toward operational efficiency and market penetration in the personalized medicine space. Investors will be monitoring the firm's ability to maintain its high-touch service model while scaling its compounding capabilities to meet increasing demand from both human and veterinary patient segments. The strategic deployment of these funds will be pivotal in establishing Pacifica Pharmacy as a leader in the specialized compounding market.
See full Pacifica Pharmacy company page
